Two murine myelomonocytic cells lines were used to examine p21 WAF1 expression in myc -induced cell transformation. tEMmyc4
C
ancer develops due to an accumulation of mutations in proto -oncogenes and /or inactivation of tumour suppressor genes. Murine v -myc ± transformed myelomonocytic cells (tEMmyc4 cells) have been shown to represent a valuable in vitro model of neoplastic progression. 1 Apart from a high level of v -myc expression, tEMmyc4 cells constitutively produce CSF -1, the monocytic growth and viability factor. 1 We have previously demonstrated that tEMmyc4 cell transformation was associated with delayed growth arrest, which resulted in apoptosis in growthinhibiting conditions.
2 V-myc down -regulation mediated by v -myc ± specific ribozymes partially restored growth arrest and delayed apoptosis. 3 Recently, we have also shown that expression of v-myc in primary murine bone marrow cells induces a similar dual effect: hyperproliferation and apoptosis were observed both in vitro and in vivo, the latter when v -myc ± expressing cells were used to reconstitute the hematopoietic system of lethally irradiated mice. 4 Increased expression of the tumor-suppressor gene p53 was observed in v-myc ± transformed cells in this reconstitution model. 4 Induction of p21 WAF1 , known to be a downstream effector of p53 and responsible for p53-mediated growth -suppressing activity, 5 was not observed in that reconstitution model. 4 It was unclear why p53 accumulation induced by v -myc resulted in apoptosis rather than in p21 WAF1 induction and consequent growth arrest. p21 WAF1 was the first cyclin -dependent kinase ( cdk) inhibitor to be identified and shown to be a downstream effector of p53 in (i) DNA damage-induced growth arrest, ( ii ) cell senescence, and (iii ) direct cdk regulation. 5 ± 10 p21 WAF1 may also play an important role in differentiationassociated growth arrest, as its expression is augmented in many terminally differentiated cells. 11 The induction of p21 WAF1 expression associated with differentiation does not depend on p53 expression.
12 ± 14 p21 WAF1 does not appear to be obligate to growth / differentiation control or tumor suppression as p21 knockout mice undergo normal development and exhibit no increase in spontaneous tumor development. 10 In this report, we show that p21 WAF1 expression appears to be impaired in v -myc ±transformed murine myelomonocytes: increased p53 expression, induced by either mitomycin C or p53 gene transfer, does not induce p21 WAF1 expression in tEMmyc4 cells. Phorbol ester 12-O -tetra -decanoylphorbol -13 -acetate ( TPA ) treatment known to induce p21 WAF1 independently of p53 also only slightly increased p21 WAF1 gene expression in these cells. p21
WAF1 expression appears to be affected by v -myc expression: elevated levels of p21 WAF1 mRNA were observed in tEMmyc4 cells with ribozyme -mediated reduced v-myc mRNA expression. 3 Moreover, enforced v -myc expression was associated with reduced p21 WAF1 mRNA levels in murine myeloid FDLV (v -myc ± transformed FDC -P1 ) cells. We also examined the effects of human p21 WAF1 gene transfer in tEMmyc4 cells. Human p21 WAF1 cDNA was engineered within a simple retroviral vector previously shown to effectively express the mutant p53 gene in murine hematopoietic cells. 15 p21 WAF1 expression resulted in a reduced frequency of clonogenic cells following CSF -1 stimulation. Such stimulation increased the S -phase cell population in parental tEMmyc4 cells, but not in p21 WAF1 expressing tEMmyc4 cells. In mitomycin C ±treated tEMmyc4 cells, which undergo transient G 2 growth arrest and rapid apoptosis rather than prolonged G 1 growth arrest, exogenous p21 WAF1 expression was found to retard cell cycling and delay apoptosis. Apoptosis induced by serum withdrawal was also delayed in p21 WAF1 -expressing cells.
MATERIALS AND METHODS

Retroviral vectors and cell transfection
The LK vector was produced by deletion of the neo sequence from the parental LNL6 vector as described previously. 15 Human p21 WAF1 cDNA (hp21 WAF1 ) was obtained from the plasmid pZLWaf1 5 a gift from Dr. B. Vogelstein ( Johns Hopkins University ). A NotI fragment, which includes the entire coding sequence, was excised from pZLWaf1 and cloned into HindIII -linearized pLK to generate pLWaf1. cDNA -encoding murine wtp53 was obtained from the plasmid pLSVN9 and a SmaI/BglII fragment was directionally cloned into BamHI /BglII -digested pLK to generate Lwtp53 (gift of Dr. K. MacKenzie ). The retroviral construct pLp53Ac5, carrying the thermosensitive murine mutant p53 ValI35 cDNA, has been described elsewhere. 15 Ten micrograms of each DNA was separately co-transfected with 1 g of pMolneo DNA (gift of Dr. M. Scott ) either by electroporation ( tEMmyc4 cells) or by lipofection ( ÉCre cells). After selection in 0.8 mg /mL of G418, resistant colonies were expanded. As a control, cells were transfected with pLK retroviral vector DNA.
Polymerase chain reaction ( PCR ) analysis
Stable integration of retroviral vectors was examined by PCR analysis of the genomic DNA isolated from the transfected cells using retrovirus -specific primers amplifying the É region of MoMLV / MSV: 5 H primer: TGG CCA GCA ACT TAT CTG TGT; 3 H primer: CAA AAA TTC AGA CGG AGG CG. The following conditions were used: 948C for 4 minutes, then 35 cycles of 948C for 30 seconds, 638C for 1 minute, and 728C for 30 seconds, followed by an elongation step of 728C for 10 minutes. To detect the human p21 WAF1 gene, the following primers were used: 5 H primer: GTC AGT TCC TTG TGG AGC CGG; 3 H primer: GAT GTA GAG CGG GCC TTT GAG, which amplifies a 533 -bp fragment of the human p21 WAF1 gene. In this case, the following conditions were used: 948C for 3 minutes, 948C for 30 seconds, 528C for 45 seconds, 728C for 1 minute, and 30 seconds for 35 cycles followed by 728C for 10 minutes for further elongation. In all cases, products were separated on a 1.5% agarose gel.
Cell culture
The tEMmyc4 cells were maintained in DMEM ( Gibco, Gaithersburg, MD ) supplemented with 10% fetal bovine serum, penicillin ( 50 U /mL ), and streptomycin ( 50 g/ mL ). L -cell conditioned medium was used as a source of CSF -1. 1 The tEMmyc4 clonal cell line expressing a v -myc ± targeted ribozyme (clone Rz1040 ) has been described elsewhere. 3 FDC -P1 and FDLV cells 4 were maintained in RPMI ( Gibco ) supplemented with 10% fetal bovine serum, antibiotics, and 10% WEHI -conditioned medium (WCM) as a source of IL -3. 16 The ÉCre cells transfected with either pLwtp53 or pLp53Ac5 DNA 15 were grown in DMEM supplemented with 10% fetal bovine serum and antibiotics.
HL -60 cells were obtained from the American Type Culture Collection and maintained in RPMI supplemented with 10% fetal bovine serum and antibiotics. To induce p21 WAF1 expression, HL -60 cells were incubated with TPA ( 100 ng/ mL ) for 48 hours.
Growth studies
Cell growth was measured over a period of 4 days. The tEMmyc4 cells ( 0.1Â10 6 cells /mL ) were plated in duplicate in a 96-well plate. Aliquots of cells were counted each day for 4 days. Doubling times were calculated from the initial exponential phase of the growth curves and the saturation densities were calculated from the plateau of the growth curve. Cell viability was measured by Trypan blue exclusion.
Colony -forming ability was assessed by plating 1000 cells/ mL in methylcellulose in triplicate. Colonies containing greater than 50 cells were scored on day 7. Statistical analysis was done using the Student's t test.
RNA preparation and Northern blot analysis
RNA was isolated using the reagent, Trizol (Gibco BRL, Grand Island, NY ) . Twenty micrograms of total RNA was loaded, separated on a 0.8% agarose -formaldehyde gel, and transferred onto Hybond-N membrane (Amersham, Buckinghamshire, U.K. ). RNA was hybridized to probes that were labeled with 32 P -dCTP by random priming. The probes employed were as follows: 2.2 kb KspI/XhoI fragment of pLwtp53 ( the murine wtp53 cDNA ) , 2.1 kb NotI fragment of pZLWaf1, -actin cDNA (Clontech, Palo Alto, CA ), 1.7 kb XhoI/HindIII fragment of v-myc cDNA isolated from pAB -v -myc plasmid, 16 and retrovirusspecific probe produced by PCR amplification of the retroviral packaging sequence ( É -probe). 15 Murine p21 WAF1 -specific probe was synthesised by reverse transcription (RT ) PCR as previously reported. 12 RNA isolated from the ÉCre cells transfected with Lp53Ac5 DNA was used for cDNA synthesis. RNA loading was evaluated by probing the same filter with similarly labeled -actin cDNA. The levels of p53 and p21 WAF1 expression were
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Electrophoretic analysis of oligonucleosomal DNA degradation
DNA fragmentation was monitored by gel electrophoresis. 17 Briefly, samples of 10 6 cells were incubated at 508C for 1 hour in 10 mM EDTA, 50 mM Tris ± HCL (pH 8.0) containing 0.5% sodium lauryl sarkosinate, and 0.5 mg / mL proteinase K ( Boehringer Mannheim, GmbH, Mannheim, Germany ). DNase -free RNase (0.5 mg / mL, Sigma, St Louis, MO ) was then added to each sample and the incubation continued at 508C for 1 hour. Samples were then heated to 708C and DNA was assessed by electrophoresis in 1.5% agarose containing ethidium bromide. DNA samples derived from equal amounts of cells were loaded. DNA bands were visualised under ultraviolet light.
Morphological studies
Cytospin preparations were made and stained for morphological characterization with May -Grunwald -Giemsa stain.
Cell surface marker studies
Surface antigens specific for the myelomonocytic lineage were determined by using fluorescently tagged monoclonal antibodies specific for CD11b and CD14 (Becton Dickinson, San Jose, CA ) by flow cytometry (FASort, Becton Dickinson ) in tEMmyc4 control cells and in p21 WAF1 expressing tEMmyc4 cells.
Immunohistochemical staining
Cells were fixed with 2.5% paraformaldehyde and dehydrated with ethanol. Antibodies used were human p21 WAF1 -specific monoclonal antibody p21 (187 ) (Pharmingen, San Diego, CA ) , murine p21 WAF1 -specific rabbit polyclonal antibody M19 ( Santa Cruz Biotechnology, Santa Cruz, CA ), antimurine p53 Ab246 ( Oncogene Science, Uniondale, NY ) , and a bax-specific polyclonal IgG ( Santa Cruz Biotechnology) . Isotypic immunoglobulins were used as a negative controls. The SIH 2 Universal Antimouse Staining Kit (Sigma Diagnostics ) was used for the detection of primary antibody binding in which 3-amino -9 -ethylcarbozole was used as a substrate for horseradish peroxidase.
Analysis of cell cycle distribution and apoptosis by flow cytometry
Experiments were performed with exponentially growing cells. To ensure exponential growth at the time of analysis, 5Â10 5 cells /mL were seeded 24 hours before analysis. TPA ( Sigma ) was used at a concentration of 100 ng/mL. Mitomycin C (Sigma ) was used at 10 ±50 g/ mL as indicated. Cells were harvested for flow cytometric analysis after 4, 6, 9, 18, 24, and 48 hours. Nocodazole (100 ng/ mL, Sigma) was added either alone or in combination with mitomycin C. Caffeine (Sigma ) was used within a concentration range of 0.1 ± 4 mM as indicated and was used either alone or in combination with mitomycin C ( 10 g/ mL ) or nocodazole (100 ng/ mL ) . Thirteen micromolars of roscovitin ( Calbiochem, Cambridge, MA) was used either alone or in combination with mitomycin C.
Serum -dependent apoptosis was analyzed by plating 5Â10 5 cells /mL in medium supplemented with either 1% or 10% fetal bovine serum. Cells were analyzed by flow cytometry or by trypan blue exclusion for 18 hours. Caffeine ( 2 mM ) was used with 10% or 1% serum.
Sample preparation for cell cycle and apoptosis analysis was as previously described. 2 Briefly, cells were washed with phosphate -buffered saline (PBS ) and stained with propidium iodide (PI ) (50 g /mL ) in the presence of 0.1% Triton X -100, 0.1% citrate, and RNase (500 U /mL ) for 1 hour at room temperature. DNA staining detected by flow cytometry data from 10,000 cells was displayed as a frequency distribution histogram of PI fluorescence after gating out of cell debris and aggregates. Analysis of histograms was performed using CellQuest software ( Becton Dickinson ) . Apoptotic cells were identified as cells with less then 2 N DNA content (sub -G 1 cells) . All experiments were performed in triplicate.
TUNEL analysis of apoptosis
DNA fragmentation was examined on cytospin preparations by the analysis of biotin -labeled dUTP incorporation into DNA. 18 In negative controls, terminal transferase was omitted. Biotin -labeled dUTP incorporation was detected using the SIH 2 Universal Antimouse staining kit (Sigma Diagnostics).
RESULTS
Aberrant p21
WAF1 expression in myc -transformed myelomonocytic cells
The p53-dependent induction of p21 WAF1 has been shown to occur in different cell types in response to DNA damage. 5 When mitomycin C, previously shown to induce elevated levels of p53 protein in mouse L929 cells, 19 was added to tEMmyc4 cells, an elevation in p53 protein was observed ( Fig 1A ) . It is relevant that not all cells within the population expressed p53; this is most likely to be associated with the asynchronicity of the culture. Interestingly, p53 expression was perinuclear rather then nuclear as is normally observed in DNA -damaged cells. p53 protein was not detected immunohistochemically in untreated tEMmyc4 cells, which is consistent with the short half -life of the protein. The conformation status of the p53 protein was determined by metabolic protein labeling and immunoprecipitation using a conformation -specific antibody. This analysis showed that wild type, rather than mutant, p53 protein was detected in tEMmyc4 cells (data not shown ). When treated with mitomycin C, p21 WAF1 protein induction was not detected immunohistochemically in tEMmyc4 cells ( Fig 1B ) . The antibody used in these experiments strongly stained the nuclei of murine hepatocytes used as a positive control (data not shown ) and was previously shown to stain liver cells when tested in bone marrow reconstituted mice. 4 By contrast, it was found that mitomycin C ± treated tEMmyc4 cells demonstrated an elevation of another p53 -regulated protein Ð bax 20 ( Fig 1C ) .
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Consistent with the lack of p21 WAF1 protein induction, p21 WAF1 mRNA levels were only weakly increased in mitomycin C ± treated tEMmyc4 cells ( Fig 2A, lanes 1  and 5) . In addition, levels of p21 WAF1 mRNA were only weakly increased in tEMmyc4 cells transfected with either the wtp53 gene or the thermosensitive mutant variant, which is equivalent to wtp53 at permissive temperature 21 ( Figs 2A, lanes 2 and 3 ) . Expression of endogenous and exogenous (wtp53 or p53 m ) p53 genes in tEMmyc4 cells is shown in Figure 2B . Control tEMmyc4 cells transfected with control pLK plasmid DNA exhibited similar levels of p21 WAF1 to nontransfected tEMmyc4 cells (data not shown) . Thus, the p53-dependent pathway of p21 WAF1 induction appears to be nonfunctional in these v-myc ± transformed cells. By contrast, the same exogenous genes, mutant p53 ( when expressed at the permissive temperature of 328C ) to a greater extent than wild type p53, were found to induce p21 WAF1 mRNA expression in murine ÉCre fibroblasts that lack v -myc ( Fig 2C) . It was found that the greater the amount of p53 (either wild type or mutant ) , the greater the degree of endogenous p21 WAF1 expression. This was true for both endogenous and exogenous p53. In addition, increased expression of mutant p53 gave rise to increased expression of wild type p53. The presence of p53 protein in all transfectants was demonstrated using conformation -specific antibodies (data not shown ). A high level of p53 in tEMmyc4 cells is consistent with previously shown up -regulation of p53 mRNA induced by ectopic myc expression in murine embryonic fibroblasts. WAF1 expression is induced by TPA in a p53-independent manner in the human myeloid leukemic cell line HL -60 with up-regulated c -myc and that this induction was associated with c -myc suppression. 23 We confirmed these results; HL -60 cells treated with TPA for 48 hours exhibited dramatically increased adherence, indicative of macrophage differentiation, with associated up -regulation of p21 WAF1 (Fig 2A, lanes 6 and 7) . By contrast, these morphological changes were not observed when tEMmyc4 cells were treated with TPA ( data not shown) and the change in p21 WAF1 was modest (Fig 2A,  lanes 1 and 4) . It is relevant that the basal level of p21 WAF1 transcript in HL -60 cells with up -regulated c-myc and lack of p53 is lower than tEMmyc4 cells. It has previously been shown that the p21 message is undetectable in growing HL -60 cells presumably due to the lack of p53. 24 We next examined the effect of v-myc modulation on levels of constitutive p21 WAF1 expression. We have previously shown that v -myc mRNA levels were decreased in tEMmyc4 cells expressing ribozymes able to cleave the v- myc ± specific transcript. 3 In the present study, cells expressing Rz1040, designed to target the v -myc transcript at nucleotide 1040 (GUU ), 3 were used. A tRNA expression cassette under the control of the murine mammary tumor virus ( MMTV ) dexamethasone -inducible promoter was used to express Rz1040 in tEMmyc4 cells. There was a level of Rz1040 constitutive expression with further induction of Rz1040 expression by dexamethasone in these cells. 3 As previously shown, 3 ribozyme -expressing tEMmyc4 cells were found to exhibit a reduction in v -myc expression and addition of dexamethasone acted to further reduce v -myc expression in Rz1040-expressing cells but not in mocktransfected tEMmyc4 cells ( Fig 3A ) . These cells were used to examine the correlation between v -myc and p21 WAF1 mRNA expression. The endogenous p21 WAF1 -specific 2.1-kb transcript was up-regulated in tEMmyc4 cells constitutively expressing Rz1040; there was also an increase in p21 WAF1 expression with dexamethasone in both mock -and (Fig 3A ) . Thus, there is an inverse correlation between levels of v -myc and p21
WAF1 . While there is not always strict proportionality to this (the myc ribozyme decreased myc levels by approximately 50% and increased p21
WAF1 by more than 10 times, whereas dexamethasone plus ribozyme had approximately 14 -fold effect in decreasing myc and increasing p21 WAF1 ), this is the trend. It is relevant that the dexamethasone -induced increase in p21 WAF1 expression correlates with an increased proportion of G 1 -arrested cells. 3 We further analyzed the effect of enforced v -myc expression in another myeloid cell line, FDC -P1, and again showed an inverse correlation between myc and p21 WAF1 levels. FDLV cells 4 also displayed reduced levels of p21
WAF1 mRNA compared to parental FDC -P1 cells ( Fig 3B ) . We next examined the effect of IL -3 withdrawal on p21 WAF1 expression in IL -3 ± dependent FDC -P1 cells and FDLV cells. It has been shown that p21 WAF1 (originally implicated in the mediation of growth arrest) can be transiently induced by certain mitogenic growth factors. 25, 26 Consistent with these results, FDC -P1 cells showed down -regulation of p21 WAF1 mRNA levels in response to IL -3 withdrawal (Fig 3B ) . By contrast, vmyc ± transformed FDLV cells did not display downregulation of p21 WAF1 after IL -3 withdrawal; in fact, a slight increase in the p21 WAF1 transcript was observed ( Fig 3B ) . The tEMmyc4 cells were not used in growth factor withdrawal experiments as these cells (due to constitutive expression of CSF -1 ) are growth factor± dependent. 1 However, other experiments were conducted in regard to mitogenic stimulation in tEMmyc4 cells ( described later ).
Exogenous human p21 WAF1 gene expression in tEMmyc4 cells
Transfection of tEMmyc4 cells with p21 WAF1 cDNA and pMolneo DNA produced G418 -resistant tEMmyc4 (p21 ) cells. PCR analysis of genomic DNA isolated from tEMmyc4( p21) cells revealed stable integration of the human p21 WAF1 gene ( Fig 4A, lane 3) . Northern blot analysis of RNA isolated from tEMmyc4( p21) cells revealed efficient expression of the retroviral sequences ( Fig 4B ) . Expression of human p21 WAF1 did not affect vmyc expression, the initiating lesion in the transformation of tEMmyc4 cells ( Fig 4B, lane 1 ) . Human p21 WAF1 encoded protein was detected immunohistochemically, showing diffuse staining in the cytoplasm and stronger dispersed staining in the nuclei of some of tEMmyc4 (p21 ) cells (Fig 4C ) . This heterogeneity in p21 staining probably reflects clonal variation in p21 WAF1 expression.
In addition, tEMmyc4 (p21 ) cells did not require exogenous growth factors for growth, similar to that of parental tEMmyc4, indicating that autocrine CSF -1 production was not significantly affected by exogenous p21 WAF1 . The tEMmyc4( p21 ) cells exhibited a growth pattern similar to control vector transfectants (doubling time approximately 11 hours and saturation cell density 2Â10 6 cells /mL ) when grown in suspension. A similar expression pattern of the monocyte ±macrophage markers, CD11b and CD14, was noted in parental tEMmyc4 cells and in tEMmyc4 (p21 ) cells with over 95% of cells expressing these markers ( data not shown) . Exogenous p21 WAF1 acts to inhibit transformation, delay cell cycle progression, and inhibit apoptosis The tEMmyc4 (p21 ) cells exhibited reduced clonogenicity compared to control cells in semisolid culture ( Table 1 ) . It was previously shown that whereas growth of tEMmyc4 cells was not dependent on exogenous CSF -1, there was a mitogenic response to exogenous CSF -1.
1 CSF -1 addition to exponentially growing tEMmyc4 cells (20% L -cell conditioned medium, 24 hours ) resulted in a reduced proportion of G 1 cells and increased proportion of S -phase cells (Fig 5A ) . By contrast, this treatment did not affect the cell cycle distribution in tEMmyc4 (p21 ) cells ( Fig 5A ) . This suggests that p21 WAF1 acts to antagonise exogenous CSF -1 mitogenic stimulation by preventing CSF -1± stimulated cell cycling.
Nocodazole, a known mitotic inhibitor, was shown to give rise to G 2 / M arrest in tEMmyc4 cells (Fig 5B ) . Delayed G 2 / M arrest was observed in tEMmyc4 ( p21) cultures treated with nocodazole. Thus, this treatment resulted in more cells remaining in G 1 and S phases in tEMmyc4( p21) cells than in control cells (Fig 5B ) . A slight increase in the number of cells in sub -G 1 , previously identified as apoptotic, was seen in both the nocodazole -treated samples consistent with its cytotoxicity. It is relevant that a small basal level of sub -G 1 cells was constantly seen in tEMmyc4 cultures, consistent with our previous findings. WAF1 was previously shown to be implicated in the p53-regulated response to DNA damage Ð p21 WAF1 induction mediating a prolonged G 1 growth arrest following DNA damage. 9 Apoptosis is another outcome of DNA damage. 27 When treated with mitomycin C, tEMmyc4 cells did not exhibit a G 1 growth arrest, rather a reduction in the G 1 cell population and subsequent accumulation in the S ±G 2 phase of the cell cycle along with an increase in apoptosis ( Fig 6A ) . Multinucleated``giant'' cells were observed in mitomycin C ± treated cultures, presumably associated with repeated rounds of DNA synthesis in these mitotically blocked cells (Fig 6B ) . Although these giant polyploid cells were detectable by flow cytometric analysis of DNA content, a significant accumulation of these cells ( > 4 N DNA content) was not observed. Rapid apoptosis probably prevents further accumulation of these giant cells. In addition, cells with DNA content higher than 4 N were seen in tEMmyc4 cells treated with nocodazole ( Fig 5B ) . The appearance of a high proportion of cells with reduced DNA content, which accumulated in the sub -G 1 population, was observed as early as 9 hours after addition of the drug (Fig 6A ) . By the end of the 24 -hour treatment, up to 50% of the cells was identified as sub -G 1 ( Fig 6A ) . The appearance of sub -G 1 cells correlated with the typical`a poptotic'' morphology characterized by nuclear condensation and fragmentation, DNA breaks, and, at later stages, significant nucleosomal DNA degradation ( Fig 7A ) . These results indicate that the giant cells rapidly enter apoptosis and that this is the reason for the lack of accumulation. It is relevant that tEMmyc4 cells were previously shown to be diploid and thus, the analysis of apoptotic cell cycling by FACS could be performed.
p21
WAF1 overexpression in tEMmyc4 cells was found to modulate cellular response to mitomycin C. Twenty -four hours following mitomycin C addition, more tEMmyc4 (p21 ) cells were found to remain in the cycle (G 1 , S, G 2 / M ) compared to control cells that demonstrated an accumulation of cells in sub -G 1 ( Fig 7B ) . Forty -eight hours after the addition of mitomycin C, both tEMmyc4 (p21 ) and control cells exhibited similar levels of sub -G 1 (data not shown) and DNA fragmentation ( Fig  7A ) . Thus, p21
WAF1 expression delays apoptosis but does not affect the overall extent of mitomycin C ± induced cytotoxicity. The delayed apoptosis seen in tEMmyc4 (p21 ) cells correlated with the delayed transition from G 1 to S ± G 2 . As previously noted, when cells were treated with mitomycin C, reduction in the proportion of G 1 cells was delayed in tEMmyc4 (p21 ) cells with time compared to control cells (Fig 7C ) . To discern whether this p21 WAF1 -mediated delay in apoptosis operates through cellular growth arrest, other growth inhibitory treatments were studied for the ability to attenuate mitomycin C ± induced apoptosis. Roscovitin, a known cdk inhibitor, produced both G 1 and G 2 growth arrest and concomitantly reduced cell numbers in untreated tEMmyc4 cells (Table 2) . Reduced sub -G 1 cells in mitomycin C ±treated cultures were observed in the presence of roscovitin ( Table 2 ) . In addition, G 2 growth delay also appears to protect tEMmyc4 cells from apoptosis; abrogation of the mitomycin C ± induced G 2 growth arrest by caffeine, a known p34 cdc2 activator which regulates the G 2 -to M-phase transition in cell cycling, 28 dramatically accelerated apoptosis in a concentration -dependent manner in tEMmyc4 cell cultures ( Table 2 ) . Caffeine addition also accelerated apoptosis in tEMmyc4 (p21 ) cells; however, p21 WAF1 -mediated protection was not abrogated completely: tEMmyc4( p21) cells consistently exhibited less sub -G 1 cells at all caffeine Cells were grown in the presence of mitomycin C ( 10 g / mL ) , roscovitin ( 13 M ) , caffeine ( 2 mM ) or combinations of these. Aliquots were taken at 9 and 18 hours, stained with propidium iodide and anlaysed by flow cytometry. Percentages do not total 100 due to gating of dead cells and aggregates. Figure 7 . Apoptosis and cell cycling in mitomycin C ± treated tEMmyc4 and tEMmyc4 ( p21 ) cells. A: DNA fragmentation. The tEMmyc4 cells transfected with control vector or pLKWaf1 were cultured in the presence of varying concentrations of mitomycin C ( 0 ± 50 g / mL ) . Genomic DNA isolated from these cultures was electrophoresed on a 1.5% agarose gel to produce the characteristic`a poptotic ladder''. B and C: Cells were grown in the presence of mitomycin C ( 10 g / mL ) for 18 hours and data were collected in the linear scale ( B ) . Aliquots of cells taken at several time periods were stained with propidium iodide and analyzed by flow cytometry. The reduction in the percentage of G 1 cells normalized to G 1 at 0 hour was plotted against time ( C ) . concentrations analyzed ( Fig 8 ) . Apparently, mitomycin C ± treated tEMmyc4 (p21 ) cells are delayed through the cell cycle, taking more time to reach G 2 , which may in turn may delay the caffeine -mediated effect.
When tEMmyc4 cells were cultured in reduced serum conditions, cell accumulation in the sub -G 1 population rather than G 1 growth arrest was observed 2 (Table 3) . Caffeine further sensitized tEMmyc4 cells to the cytopathic effect of serum withdrawal by acceleration of S ±G 2 / M transition (Table 3 ). tEMmyc4 ( p21) cells appear to be more resistant to serum withdrawal: consistently less sub -G 1 cells were observed 24 hours following serum withdrawal with more cells remaining in S ±G 2 / M compared to control cells ( Table 3 ) . Caffeine sensitised tEMmyc4 (p21 ) cells to serum withdrawal in a similar manner to that seen in parental tEMmyc4 cells.
DISCUSSION
Cells with functional tumor-suppressor p53 protein normally accumulate this protein in response to DNA damage, 19 which in turn induces p21 WAF1 and subsequent growth arrest. 9, 29 While increased p53 expression was observed in mitomycin C ± treated tEMmyc4 cells, neither p21 WAF1 mRNA nor p21 protein was induced. Because another p53-regulated protein, bax, 20 was induced in mitomycin C ± treated tEMmyc4 cells, it is likely that the transcription activity of p53 was not impaired in tEMmyc4 cells, although p53 -independent induction of bax cannot be excluded. Only weak induction of p21 WAF1 mRNAwas found in tEMmyc4 cells with enforced expression of either wild type p53 or the thermosensitive mutant variant, 21 which performs like wtp53 at the permissive temperature. This may be due to the relatively low level ( similar to endogenous ) of p53 in these cells. It is relevant that both p53 genes, when expressed in ÉCre cells, were able to up -regulate p21 WAF1 mRNA expression. The p53 -independent induction of p21 WAF1 expression by TPA has previously been shown to be associated with the induction of terminal growth arrest and differentiation. 13, 14 TPA, which induces p21 WAF1 expression and terminal differentiation in HL -60 cells, 14, 23 induced p21 WAF1 mRNA only slightly in tEMmyc4 cells with no maturation. It is relevant that c -myc expression was down -regulated by TPA in HL -60 cells that normally exhibit increased c -myc expression.
14 This prompted us to examine whether p21 WAF1 expression was altered by the modulation of vmyc expression in tEMmyc4 cells. tEMmyc4 cells transfected with the v -myc ribozyme expressed less v -myc mRNA with consequent up -regulation of p21
WAF1 , compared to the untransfected tEMmyc4 cells. In addition, enforced v -myc expression was associated with decreased p21 WAF1 mRNA in FDLV cells. It is relevant that overexpression of c -myc was recently shown to inhibit p21 WAF1 expression and induced S -phase entry in TPA -sensitive human cancer cells. 12 In two publications addressing the issue of myc overexpression, Mitchell and El-Deiry 12 showed that overexpression of c -myc inhibited p21 WAF1 expression and induced S -phase entry in TPA -sensitive breast and prostate cancer cell lines and Hermeking et al 30 showed that enforced myc expression acted to decrease p21 activity by induction of a p21 WAF1 protein inhibitor. One possible mechanism that down -regulates p21 WAF1 in myc -overexpressing cells has been recently shown to act through inactivation of arf even with p53 up -regulation. 22 We next examined the effect of enforced human p21 WAF1 expression in tEMmyc4 cells. p21 WAF1 transfectants produced less colonies compared to vector alone ± transfected Aliquots of cells were taken 18 hours following treatment, stained with propidium iodide and analysed by flow cytometry. No G1 growth arrest, reduction in G1, increase in G2 / M, increase in apoptosis
Remain in cycle, delay in apoptosis Addition of roscovitin ( Table 2 ) G1 and G2 / M growth arrest ND Addition of mitomycin and roscovitin ( Table 2 ) Roscovitin protects from mitomycin induced apoptosis ND Addition of caffeine ( Tables 2 and 3 ) Reduction in G2 / M, increase in apoptosis Reduction in G2 / M, increase in apoptosis, sensitised to serum withdrawal Addition of caffeine and mitomycin ( Table 2 ) Accelerates mitomycin induced apoptosis ND FCS withdrawal ( Table 3 ) Increase in apoptosis, decrease in S Delay in apoptosis, increase in S and G2 / M Addition of caffeine and FCS withdrawal ( Table 3 ) Greater reduction in G2 / M, greater increase in apoptosis Table 4 . While the addition of CSF -1 acted to modify cell cycling in tEMmyc4 cells, no changes were observed in tEMmyc4( p21) cells. Retarded cell cycling was observed in nocodazole -treated tEMmyc4 cultures and this was less apparent in tEMmyc4 (p21 ) cells. Enforced p21 WAF1 expression also affected the cellular response to mitomycin C ( Table 4 ) . Flow cytometric analysis of cell cycling revealed that tEMmyc4 cells lack functional G 1 growth arrest: mitomycin C ± treated tEMmyc4 cells transiently accumulate in the S ± G 2 / M phases and then rapidly die due to apoptosis. Lack of functional G 1 growth arrest was also observed in tEMmyc4 cells treated with aphidicolin, a known inhibitor of DNA polymerase which normally produces a prolonged and reversible G 1 growth arrest in 3T3 cells or in hematopoietic TF -1 cells. In the tEMmyc4 cells, however, aphidicolin induced rapid apoptosis (unpublished data ).
In addition, mitomycin C appeared to induce uncoupling of S phase and mitosis in tEMmyc4 cells: multinucleated giant cells were observed in mitomycin C ± treated cultures, presumably due to the repeated rounds of DNA synthesis. A similar dysfunction of G 1 growth arrest, transient G 2 / M block, uncoupling of S phase, and mitosis and rapid apoptosis in response to DNA damage has been recently reported in murine bone marrow cells and thymocytes with dysfunctional p53 31 and in p21 WAF1 -defective colorectal epithelial cells. 32 Experiments to this point thus showed that the myctransformed cells exhibited similar features to p21 defective cells, namely dysfunctional G 1 and G 2 growth arrest and susceptibility to DNA -induced apoptosis. The next question that was addressed was the mechanism of reversal of transformation by p21
WAF1
. Mitomycin C ± induced apoptosis was significantly delayed in tEMmyc4 (p21 ) cells, although the overall extent of cell death was similar in control and tEMmyc4 (p21 ) cells at the latest time point, 48 hours after mitomycin C was added. It is likely that p21 WAF1 exerts its protective influence through the effect on cell cycling because of a G 1 growth arrest mediated by roscovitin -delayed mitomycin C ± induced apoptosis. G 2 growth arrest also appears to delay mitomycin C ± induced apoptosis in tEMmyc4 cells: abrogation of G 2 growth arrest by caffeine sensitised tEMmyc4 cells both to mitomycin C and serum withdrawal. The tEMmyc4 ( p21) cells appear to reach the G 2 point significantly later compared to control cells and this, in turn, appears to delay the onset of apoptosis. It is relevant that p21 inactivation has been shown to result in the abrogation of the G 2 / M block induced by DNA damage and subsequently accelerated apoptosis in human colorectal cancer cells. 33 The tEMmyc4 ( p21) cells also exhibited a transient delay in the onset of apoptosis induced by serum withdrawal and the latter correlates with restoration of growth arrest. It is relevant that elevated p21 WAF1 expression in tEMmyc4 cells expressing Rz1040 and thus reduced v-myc also correlated with delayed dexamethasone -induced apoptosis. 3 It was recently reported that p21 WAF1 conferred resistance to apoptosis during myocyte differentiation. 34 p21 WAF1 expression is required for the survival of differentiating SH -SY5Y neuroblastoma cells, 35 suggesting that this is a normal function of p21 WAF1 . In addition, p21 waf1 overexpression was shown to produce a protective effect against apoptosis induced by prostaglandin 2 in both breast and colorectal carcinoma cells. 36 The p21-induced cycle arrest in G 1 protects human epidermal carcinoma A431 cells from apoptosis induced by UV irradiation or RNA polymerase II blockage.
37 p21 WAF1 overexpression has been recently shown to protect primary chicken embryo fibroblasts from E2F1 -induced apoptosis. 38 In addition, a high level of p21 WAF1 expression correlates with resistance to certain chemotherapeutic treatments in human leukemias; 39 loss of p21 WAF1 sensitised tumors to radiation 40 and caspase cleavage of p21 WAF1 was recently shown to mediate apoptosis in endothelial cells. 41 Another cdk inhibitor, p16 ink4a , has also been shown to inhibit apoptosis in leukemic cells 42 and the cdk inhibitor, p27, has been shown to delay cell cycle progression and inhibit apoptosis. 43 Similar to our finding of cytoplasmic staining of exogenous p21, Asada et al 44 have shown that cytoplasmic p21 acts to inhibit apoptosis.
CONCLUSION
These data indicate that reduced p21 WAF1 is implicated in myc -induced cell transformation and restoration of p21 WAF1 acts to reverse this transformation at least in certain cell lines. Our data also indicate that restoration of p21 WAF1 expression acts to reduce sensitivity of myc -overexpressing cancer cells to DNA -damaging agents used in chemotherapy. Protocols to affect tumour cell reversion could be, as shown here, the introduction of p21 WAF1 cDNA into transformed malignant cells or associated strategies such as acting on downstream effectors of p21 WAF1 action. Either of these approaches would act on both p53-dependent and p53 -independent pathways and may thus have an advantage over p53. In keeping with this, the present data indicate that gene therapy targeting p21
WAF1 could be applied following chemotherapy to inhibit proliferation of resistant cells.
